Delinia

Delinia aims to discover and develop novel therapeutics targeting regulatory T cells for the treatment of autoimmune and inflammatory diseases

[Dr. Sue Desmond-Hellmann @SueDHellmann]

No ifs, ands or buts! This data viz shows how remarkably effective vaccines are at fighting infectious disease.
https://t.co/Hl8OZNnmoH

[Mathai Mammen @mmammen]

This one is well worth contemplating https://t.co/5p7tIPa6qw

[Delinia @Deliniabio]

Just Four Months After Series A, Delinia Sells to Celgene For $300M https://t.co/CEumQxYlJh via @xconomy

[Delinia @Deliniabio]

Delinia Delivers An Exciting Autoimmune Therapy To Celgene via @forbes https://t.co/URfoG5Yk3Z

[Delinia @Deliniabio]

Celgene to Acquire Delinia, Inc. | Business Wire https://t.co/1qVZGanHkg

[Asher Mullard @AsherMullard]

A map of 1578 FDA-approved drugs, by their 856 targets. https://t.co/e6vesW2wHL

[Delinia @Deliniabio]

How Delinia is threading the IL-2 needle in autoimmunity https://t.co/ZcirdhsiWt

[John Carroll @JohnCendpts]

Enjoyed talking to Saurabh Sara today about his autoimmune #biotech startup --
https://t.co/5cWLqc0uXc

[Atlas Venture @atlasventure]

We are proud to announce three new companies that recently launched in our portfolio: @avrobio @Deliniabio #IFMTherapeutics

[Nature Medicine @NatureMedicine]

Low-dose IL-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic #lupus erythematosus: https://t.co/KRR7WFrfE7

[Delinia @Deliniabio]

Re-Balancing Immunity via Regulatory T Cell Potentiation: Introducing Delinia https://t.co/ZFdpHrfYib

[Delinia @Deliniabio]

Sofinnova, Atlas lead next-gen autoimmune upstart’s $35M Series A https://t.co/4cUHpXvue4

[Delinia @Deliniabio]

Delinia Raises $35M Series A for Autoimmune Drug Development https://t.co/AuxtEVCJqi via @WSJ

[Delinia @Deliniabio]

Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases https://t.co/20BSxR5b6T via @xconomy

[Delinia @Deliniabio]

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting... | Business Wire https://t.co/lnxs24Q13P